MicroRNA‑23a/24‑2/27a as a potential diagnostic biomarker for cancer: A systematic review and meta‑analysis

Abstract

Abstract. An increasing number of studies have proven that microRNAs play an important role in the occurrence, development and prognosis of various types of cancer. As a vital gene cluster, the microRNA (miR)-23a/24-2/27a cluster may be an important marker for predicting cancer prognosis and tumor progression. A search was conducted through PubMed, Medline and the Cochrane Library to identify studies investigating the association between the miR-23a/24-2/27a cluster and cancer, and the identified related studies were included in the present meta-analysis. The strength of the association was assessed by hazard ratio (HR) and its 95% confidence interval (95% CI). A total of 21 studies were included in this meta-analysis. The results indicated that a high level of miR-23a exerted a significant effect on overall survival (OS) (HR=2.33, 95% CI: 1.18-4.58; P=0.014), but not on disease-free survival (DFS)/recurrence-free survival (RFS) (HR=1.13, 95% CI: 0.37-3.44; P=0.836). There was an obvious statistically significant association between OS and the expression of miR-24 (HR=2.49, 95% CI: 1.84-3.37; P=0.000), particularly in the digestive system (pooled HR=2.99, 95% CI: 2.17-4.13, P=0.000). In addition, the result suggested a statistically significant association between the expression of miR-27a and OS (pooled HR=1.89, 95% CI: 1.32-2.69; P=0.001), as well as DFS/RFS/progression-free survival (HR=2.19, 95% CI: 1.29-3.70; P=0.003), particularly in renal cell carcinoma (HR=2.30, 95% CI: 1.16-4.67; P=0.017). A subgroup analysis by ethnicity, cancer type and statistical methodology was performed. There was no obvious publication bias. In conclusion, the present study demonstrated that the miR-23a/24-2/27a cluster may be a useful marker for predicting cancer prognosis and tumor progression. IntroductionMicroRNAs (miRNAs, miRs) are ~22-nucleotide long, single-stranded non-coding RNA molecules (1). They were first discovered in the nematode Caenorhabditis elegans with the identification of the developmental regulator lin-4 (2). Thus far, there are ~2,588 annotated miRNAs found in the human genome (3). With advances in research, it has been demonstrated that miRNAs may play an important role in various diseases. An increasing number of miRNAs were proven to participate in crucial biological processes, such as cell proliferation, migration, invasion and apoptosis (4-7), which may enable use of the miRNA family in the diagnosis and treatment of disease, due to the extensive alterations in miRNA expression in different diseases.miR-23a/24-2/27a encodes a ~2,159-nt pri-miRNA transcript, which is located in chromosome 19p13.12 as an intergenic miRNA cluster (8). The profiling analysis suggested that the miR-23a/24-2/27a cluster was significantly upregulated in hepatocellular carcinoma (HCC) (9), pancreatic adenocarcinoma (10) and breast cancer (11). There are several studies on the association of the miR-23a/24-2/27a cluster with various types of cancer. Thus, the present systematic review and meta-analysis were designed to confirm...

MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2

“…19 According to the examination, highly expressed miR-23a in cancers of the digestive system was associated with a poor prognosis. 20 Another study demonstrated that OC tissues had a high miR-23a expression, which was consistent with our findings. 21 In addition, DLG2 was found to be downregulated in oropharyngeal squamous cell carcinoma.…”

Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis

“…Alternatively, constitutively expressed miR-31 may simply be diluted out in early infection by the vast influx of immune cells and associated soluble mediators including microRNAs such as miR-223. A similar explanation may explain why levels of miR-21 and miR-27a are lower during peritonitis than in stable patients, two microRNAs that are expressed at similar levels by both resident tissues and infiltrating immune cells 27,28 .…”

microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance

“…A meta-analysis including different kinds of human cancer suggested that an overall high level of miR-23a predicted the overall patients’ survival (HR = 2.33, 95% CI: 1.18–4.58; p = 0.014) but not a disease-free/recurrence-free survival (HR = 1.13, 95% CI: 0.37–3.44; p = 0.836). In a subgroup analysis, miR-23a expression predicted poor overall survival in digestive system cancer but not in respiratory cancer [66].…”